The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

FAH

—Fumarylacetoacetate Hydrolase

Chromosome: 15

Location: 15:80152292-80186990

OMIM: 613871

Ensembl: ENSG00000103876

Official·OMIM:613871 Official·ENSG00000103876

Encodes fumarylacetoacetate hydrolase enzyme. Mutations cause tyrosinemia type 1.

Treatment Roadmap — FAH

Preclinical

Phase 1

Phase 2

4 trial

Phase 3

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Tyrosinemia Type 1

Autosomal RecessivePrevalence: 1/100000hepatic

Official·OMIM:276700 Official·ORPHA882

Summary

Clinical Trial

Approved Therapy

Registered Variant